Consensus Metagenomi, Inc.

Equities

MGX

US59102M1045

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
6.8 ^USD	+3.98%		0.00%	0.00%

May. 07	HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target	MT
May. 03	North American Morning Briefing : Apple, Amgen -2-	DJ

Evolution of the average Target Price on Metagenomi, Inc.

Price target over the last 5 years

History of analyst recommendation changes

dfc3199950b8bc2ff580835f.d75Y_vqnbn-yIW0o58IBv-ZorPIVv3GV2qInbr-YckM.I9hojbPfDx6KfgZQrJ1R6YMM2rZd5jOgivVzGYzpRCsc0Ay1vJ4GLsN3NA~ca3b4bec260e4903d19e9b9307d33619

Analyst Recommendations on Metagenomi, Inc.

HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target	May. 07	MT
Chardan Research Lowers Metagenomi's PT to $17 From $21 on Heels of Announced Termination of Collaboration With Moderna, Keeps Buy Rating	May. 02	MT
JPMorgan Downgrades Metagenomi to Neutral, Price Target at $6	May. 02	MT
TD Cowen Initiates Metagenomi With Outperform Rating	Mar. 05	MT
Jefferies Starts Metagenomi With Buy Rating, $23 Price Target	Mar. 05	MT
BMO Capital Starts Metagenomi With Outperform Rating, $22 Price Target	Mar. 05	MT
Wells Fargo Starts Metagenomi With Overweight Rating, $25 Price Target	Mar. 05	MT
JPMorgan Starts Metagenomi With Overweight Rating, $16 Price Target	Mar. 05	MT
Chardan Starts Metagenomi With Buy Rating, Price Target is $21	Mar. 05	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.8 USD

Average target price

16.83 USD

Spread / Average Target

+147.55%

High Price Target

25 USD

Spread / Highest target

+267.65%

Low Price Target

6 USD

Spread / Lowest Target

-11.76%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Metagenomi, Inc.

HC Wainwright
Chardan Research
JPMorgan Chase
TD Cowen
Wells Fargo Securities
BMO Capital
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar